Melola Discovery

← Melola Discovery

Jurnal SINTA 1

A Brief Outlook on Pharmacogenetics (PGx): Focus in MicroRNAs (miRNAs) and Cancer Stem Cells (CSCs)

Indonesian Journal of Cancer Chemoprevention · Vol. 10 No. 1 (2019) · hlm. 46–50

DOI
10.14499/indonesianjcanchemoprev10iss1pp46-50
ISSN
2355-8989, 2088-0197
Terbit
2019-02-28
Penerbit
Indonesian Society for Cancer Chemoprevention
Bahasa
eng

Abstrak

It has been known that there are differences in response to medications both in terms of clinical activity and side effects. Among all influencing factors, genetic variation has been considered to play a crucial part. By genetic investigation, the differences in drug metabolism, transport and target could be disclosed. Termed as “pharmacogenetics (PGx)”, that focuses on the variants within one or more candidate genes. Genetic tests have been started for screening polymorphisms prior to drug prescription, moreover many biomarkers were developed in oncology. Recent PGx investigations have been conducted to identify mRNAs, microRNAs (miRNAs) and other downstream signals that are affected by variation in genes that might cause drug response variability. Another intriguing study related to PGx in cancer stem cells (CSCs) has recently aroused. CSC shows more resistant behavior to drug. CSCs are subpopulation of cells, which share some same markers with stem cells. CSC can induce specific signal transduction pathways. Variation in genes affect CSCs activity are generally neglected in the past PGx studies. This could be one of the explanation why past PGx studies in cancer cell do not achieve optimal clinical outcome. Keywords: pharmacogenetics, pharmacogenomics, microRNAs, cancer stem cells

Jaringan kolaborasi para penulis

38 penulis · 125 tautan kepenulisan bersama · 34 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Trisakti
  • Maranatha Christian University
  • Universitas Islam Negeri Maulana Malik Ibrahim
  • Universitas Wahid Hasyim
  • University of Indonesia
  • Indonesian Institute of Sciences
  • Universitas Airlangga
  • Organisasi lain
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Wahyu WidowatiMaranatha Christian University2
Tjandrawati MozefIndonesian Institute of Sciences2
Janti SudionoUniversitas Trisakti1
Nadya Saputri HalimAfiliasi tidak diketahui1
Timotius Andi KadriantoAfiliasi tidak diketahui1
Melinia MeliniaAfiliasi tidak diketahui1
Rahmi AmthaUniversitas Trisakti1
Diah Savitri ErnawatiUniversitas Airlangga1
Indrayadi GunardiUniversitas Trisakti1
Roihatul MutiahUniversitas Islam Negeri Maulana Malik Ibrahim1
Farenza Okta KiranaUniversitas Islam Negeri Maulana Malik Ibrahim1
Rahmi AnnisaUniversitas Islam Negeri Maulana Malik Ibrahim1
Ana RahmawatiUniversitas Islam Negeri Maulana Malik Ibrahim1
Junita BriskilaUniversitas Trisakti1
Ketherin KetherinUniversitas Trisakti1
Dian Ratih LaksmitawatiAfiliasi tidak diketahui1
Jeanne Adiwinata PawitanUniversity of Indonesia1
Caroline T. SardjonoMaranatha Christian University1
Mohammad SadikinUniversity of Indonesia1
Devi Nisa HidayatiUniversitas Wahid Hasyim1
Fitriasih FitriasihUniversitas Wahid Hasyim1
Siti Mega KomariyahUniversitas Wahid Hasyim1
Nenni PratiwiUniversitas Wahid Hasyim1
Hana RatnawatiMaranatha Christian University1
Chandra RisdianIndonesian Institute of Sciences1
Susi TjahyaniMaranatha Christian University1
Jackson JacksonUniversitas Trisakti1
Johni HalimUniversitas Trisakti1
Rezky AnggraeniUniversitas Trisakti1
Dwi Davidson RihibihaAfiliasi tidak diketahui1
Annisa AmaliaBandung Institute of Technology1
Ervi AfifahAfiliasi tidak diketahui1
Rizal RizalUniversity of Indonesia1
Harry MurtiAfiliasi tidak diketahui1
Indra BachtiarAfiliasi tidak diketahui1
Seila ArumwardanaAfiliasi tidak diketahui1
Hayatun NufusAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ijcc.chemoprev.org/index.php/ijcc/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">A Brief Outlook on Pharmacogenetics (PGx): Focus in MicroRNAs (miRNAs) and Cancer Stem Cells (CSCs)</dc:title>
	<dc:creator>Sandra, Ferry</dc:creator>
	<dc:description xml:lang="en-US">It has been known that there are differences in response to medications both in terms of clinical activity and side effects. Among all influencing factors, genetic variation has been considered to play a crucial part. By genetic investigation, the differences in drug metabolism, transport and target could be disclosed. Termed as “pharmacogenetics (PGx)”, that focuses on the variants within one or more candidate genes. Genetic tests have been started for screening polymorphisms prior to drug prescription, moreover many biomarkers were developed in oncology. Recent PGx investigations have been conducted to identify mRNAs, microRNAs (miRNAs) and other downstream signals that are affected by variation in genes that might cause drug response variability. Another intriguing study related to PGx in cancer stem cells (CSCs) has recently aroused. CSC shows more resistant behavior to drug. CSCs are subpopulation of cells, which share some same markers with stem cells. CSC can induce specific signal transduction pathways. Variation in genes affect CSCs activity are generally neglected in the past PGx studies. This could be one of the explanation why past PGx studies in cancer cell do not achieve optimal clinical outcome. Keywords : pharmacogenetics, pharmacogenomics, microRNAs, cancer stem cells</dc:description>
	<dc:publisher xml:lang="en-US">Indonesian Society for Cancer Chemoprevention</dc:publisher>
	<dc:contributor xml:lang="en-US"></dc:contributor>
	<dc:date>2019-02-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ijcc.chemoprev.org/index.php/ijcc/article/view/264</dc:identifier>
	<dc:identifier>10.14499/indonesianjcanchemoprev10iss1pp46-50</dc:identifier>
	<dc:source xml:lang="en-US">Indonesian Journal of Cancer Chemoprevention; Vol 10, No 1 (2019); 46-50</dc:source>
	<dc:source>2355-8989</dc:source>
	<dc:source>2088-0197</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ijcc.chemoprev.org/index.php/ijcc/article/view/264/179</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2019 Ferry Sandra</dc:rights>
</oai_dc:dc>